• Science & Technology
• Health & Medicine

News digest – cervical cancer progress, new immune cell, breast cancer scans and repurposed drugs

In the news this week:  cervical cancer progress in Britain has stalled in the last decade, as screening uptake remains stubbornly low. In the news this week:  cervical cancer progress in Britain has stalled in the last decade, as screening uptake remains stubbornly low.

25 January 2020

• Health & Medicine

Leukaemia and head and neck cancer drugs not approved for NHS use in England

Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England. Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.

23 January 2020

• Health & Medicine

Cervical cancer progress falters as screening uptake hits record lows

Cervical cancer rates in Britain halved between the late 1980s and mid-2000s - but new CRUK figures warn that progress has since been stalling and stagnating. Cervical cancer rates in Britain halved between the late 1980s and mid-2000s - but new CRUK figures warn that progress has since been stalling and stagnating.

22 January 2020

• Health & Medicine

Hormone therapy now available for newly diagnosed prostate cancer in Scotland 

A hormone therapy has been approved for NHS use in Scotland for some people with newly diagnosed, advanced prostate cancer for the first time.   A hormone therapy has been approved for NHS use in Scotland for some people with newly diagnosed, advanced prostate cancer for the first time.  

20 January 2020

• Science & Technology
• Health & Medicine

News digest – NHS drug decision, cost of cancer, missed GP appointments and prostate cancer deaths

In the news this week: a new type of targeted cancer drug is initial rejected for use on the NHS in England In the news this week: a new type of targeted cancer drug is initial rejected for use on the NHS in England

18 January 2020

• Health & Medicine

New breed of targeted cancer drug gets initial ‘no’ for NHS in England  

A targeted drug, larotrectinib (Vitrakvi), will not be made an option for adults and children whose tumours test positive for a specific genetic change. A targeted drug, larotrectinib (Vitrakvi), will not be made an option for adults and children whose tumours test positive for a specific genetic change.

15 January 2020

• Health & Medicine
• Science & Technology

News digest – transforming clinical trials, AI and brain surgery, vaping and breast cancer genetics

In the news this week: our scientists want to transform the way clinical trials are run and 191 genes are linked to breast cancer development in new research. In the news this week: our scientists want to transform the way clinical trials are run and 191 genes are linked to breast cancer development in new research.

11 January 2020

• Health & Medicine

Lung cancer immunotherapy gets initial ‘no’ for NHS in England

An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England. An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England.

8 January 2020

• Health & Medicine

Complex innovative trials: Authors call for new guideline adoption to get medicines to patients faster

Complex Innovative Design trials could be transformed for the better, following the publication of ten recommendations in the British Journal of Cancer. Complex Innovative Design trials could be transformed for the better, following the publication of ten recommendations in the British Journal of Cancer.

6 January 2020

• Science & Technology
• Health & Medicine

News digest – breast screening AI, NHS waiting times, brain tumour scans and ‘prehab’

In the news this week: AI software is just as good as a radiologist at spotting breast cancer in screening images. In the news this week: AI software is just as good as a radiologist at spotting breast cancer in screening images.

4 January 2020

• Health & Medicine

Artificial intelligence could help breast screening save more lives

We’ve helped Google Health with AI research which has the potential to improve breast cancer screening and save the NHS time and money. We’ve helped Google Health with AI research which has the potential to improve breast cancer screening and save the NHS time and money.

1 January 2020

• Science & Technology
• Health & Medicine

News digest – prostate cancer MRI trial, drug delivery, cancer ‘cures’ on Facebook and weight loss

In the news this week: WHO approves a cheap copy of a common breast cancer drug that could save the lives of women in low income countries. In the news this week: WHO approves a cheap copy of a common breast cancer drug that could save the lives of women in low income countries.

21 December 2019